Investors & Media International Stem Cell Corporation Updates on Marketing Strategy of its Subsidiary Lifeline Skin Care Kenneth Aldrich, Executive Chairman of International Stem Cell Corporation, Will Make a Public Appearance March 16, 2011 on Behalf of ISCO International Stem Cell Corporation Receives Important Approvals Towards Creating New Parthenogenetic Stem Cell Lines in the United States International Stem Cell Corporation Updates on 2010 Initial Product Launch of its Lifeline Skin Care Products International Stem Cell Demonstrates Progress in the Use of Immune Matched Human Parthenogenetic Stem Cells to Promote the Development of Therapies for Diabetes and Liver Diseases International Stem Cell's Scientists in Collaboration with World-Leading Stem Cell Experts Extend Understanding of Human Parthenogenetic Stem Cells in Peer-Reviewed Publications International Stem Cell Applauds Research Showing Parthenogenesis as a Potential Strategy for Treating Inherited Disease International Stem Cell Corporation Announces Company Update Conference Call International Stem Cell Corporation to Present Ethical and Technical Qualities of Human Parthenogenetic Stem Cells at the Center for Ethics in Science and Technology International Stem Cell Corporation Announces Start of Marketing Collaboration with John Mauldin for Skin Care Products 19 20 21 22 23 24 25 26 27 28 29 << < > >>
